0001870913-24-000002.txt : 20240118 0001870913-24-000002.hdr.sgml : 20240118 20240118182010 ACCESSION NUMBER: 0001870913-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240116 FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shanmugam Muthusamy CENTRAL INDEX KEY: 0001870913 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 24543201 MAIL ADDRESS: STREET 1: C/O ANI PHARMACEUTICALS, INC. STREET 2: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 wk-form4_1705619998.xml FORM 4 X0508 4 2024-01-16 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001870913 Shanmugam Muthusamy C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 1 1 0 0 HEAD OF R&D, COO-NOVITIUM OPS 1 Common Stock 47407 D Common Stock 2024-01-16 4 S 0 5000 55.63 D 927620 I Held by Esjay LLC Common Stock 2024-01-17 4 S 0 10000 55.11 D 917620 I Held by Esjay LLC Common Stock 2024-01-18 4 S 0 9784 55.30 D 907836 I Held by Esjay LLC Common Stock 5000 I Held by SS Pharma LLC The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.99 to $56.71, inclusive. The reporting person holds voting and dispositive power over the shares held by Esjay LLC. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.59 to $55.57, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.70 to $55.73, inclusive. The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook 2024-01-18